Bushu Pharma Lauded by Frost & Sullivan for Enabling the Launch of Specialty Drugs in Japan and Asia-Pacific and Offering Customer Value with Its Advanced Gateway to Asia Services
Frost & Sullivan
JULY 26, 2022
Bushu Pharma works closely with its partners to help organizations successfully launch their products, even with minimal resources. It eliminates delivery delays, compromised drug environments, and long lead times,” as noted by Surbhi Gupta, Senior Industry Analyst for Frost & Sullivan.
Let's personalize your content